Renaissance Capital logo

Know Labs Priced, NYSE American: KNW

Developing a non-invasive glucose monitor using biosensor technology.

Industry: Health Care

Latest Trade: $0.23 0.00 (0.0%)

First Day Return: +5.0%

Return from IPO: -88.5%

Industry: Health Care

Know Labs is focused on the development and commercialization of proprietary biosensor technologies which, when paired with our artificial intelligence, or AI, deep learning platform, are capable of uniquely identifying and measuring almost any material or analyte using electromagnetic energy to detect, record, identify and measure the unique “signature” of said materials or analytes. We call these our “Bio-RFID™” technology platform when pertaining to radio and microwave spectroscopy; and “ChromaID” technology platform when pertaining to optical spectroscopy. The data obtained with our biosensor technology is analyzed with our trade secret algorithms which are driven by our AI deep learning platform. There are a significant number of analytes in the human body that relate to health and wellness. Our focus is upon those analytes relating to human health, the identification of which provide diagnostic information and require, by their nature, clearance by the United States Food and Drug Administration.
more less
IPO Data
IPO File Date 07/29/2022
Offer Price $2.00
Price Range $2.00 - $2.00
Offer Shares (mm) 3.6
Deal Size ($mm) $7
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 09/15/2022
Offer Price $2.00
Price Range $2.00 - $2.00
Offer Shares (mm) 3.6
Deal Size ($mm) $7
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
Boustead Securities
Company Data
Headquarters Seattle, WA, United States
Founded 1998
Employees at IPO 15
Website www.knowlabs.co

Know Labs (KNW) Performance